Predictors of carotid plaque progression over a 4-year follow-up in the Reykjavik REFINE-study

Carotid plaque is an arterial marker suggested as a surrogate end point for cardiovascular disease. The aim of this study was to examine the association of risk factors at visit 1 with plaque formation and progression of total plaque area (TPA) during follow-up. We examined 1894 participants (50–69...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis Jg. 269; S. 57 - 62
Hauptverfasser: Sturlaugsdottir, Ran, Aspelund, Thor, Bjornsdottir, Gudlaug, Sigurdsson, Sigurdur, Thorsson, Bolli, Eiriksdottir, Gudny, Gudnason, Vilmundur
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Ireland Elsevier B.V 01.02.2018
Schlagworte:
Aged
Carotid Artery Diseases - diagnostic imaging
Carotid Artery Diseases - drug therapy
Carotid Artery Diseases - epidemiology
Carotid Artery, Common - diagnostic imaging
Carotid Artery, Common - drug effects
Carotid Intima-Media Thickness
Carotid ultrasound
Disease Progression
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Iceland - epidemiology
Longitudinal Studies
Male
Middle Aged
Plaque progression
Plaque, Atherosclerotic
Predictive Value of Tests
Prospective Studies
Risk Factors
Time Factors
Iceland
Risk factors
Plaque progression
Carotid ultrasound
ISSN:0021-9150, 1879-1484, 1879-1484
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Carotid plaque is an arterial marker suggested as a surrogate end point for cardiovascular disease. The aim of this study was to examine the association of risk factors at visit 1 with plaque formation and progression of total plaque area (TPA) during follow-up. We examined 1894 participants (50–69 years of age) in the population-based REFINE (Risk Evaluation For INfarct Estimates)-Reykjavik study. Among those with no plaque at baseline, plaque formation was associated with low density lipoprotein, sex, waist, former smoker and physical activity. Furthermore, both the Icelandic Heart Association (IHA) coronary heart disease (CHD) risk score and the atherosclerotic cardiovascular disease (ASCVD) risk score were highly associated with plaque formation in these individuals (p < 0.001) and a better cardiovascular health score was protective. In those with plaque present at baseline, metabolic syndrome was associated with increased risk, while older age and statin use were associated with reduced risk of new plaque formation. Statin use was the only factor associated with the relative TPA progression, where participants not on treatment had 5.7% (p=0.029) greater rate of progression compared with statin users. A number of conventional risk factors at visit 1 were individually associated with plaque formation, also when combined into CHD and ASCVD risk scores, but not with the relative progression in TPA. Medical intervention with statins can reduce the relative progression rate of TPA in the general population with low grade of atherosclerosis, supporting statin use to slow progression of atherosclerosis. •Cardiovascular risk factors were associated with formation of new carotid plaque in 4 years.•Cardiovascular risk factors were not associated with relative increase in total plaque area in 4 years.•Intervention with statins were significantly associated with reduced progression of total plaque area in 4 years.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9150
1879-1484
1879-1484
DOI:10.1016/j.atherosclerosis.2017.12.005